About the Authors
- Xinqi Wu
-
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Melanoma Disease Center, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts, United States of America
- Melina E. Marmarelis
-
Affiliation Harvard Medical School, Boston, Massachusetts, United States of America
- F. Stephen Hodi
-
* E-mail: stephen_hodi@dfci.harvard.edu
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Melanoma Disease Center, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts, United States of America
Competing Interests
The authors have the following interests. F.S.H. has served as a non-paid consultant to Synta Pharmaceuticals and received clinical trial support from Synta Pharmaceuticals. Ganetespib used in this study was provided by Synta Pharmaceuticals Corp. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: XW MEM FSH. Performed the experiments: XW MEM. Analyzed the data: XW MEM FSH. Wrote the paper: XW MEM FSH.